Pharming (PHAR) Profit After Tax (2020 - 2026)
Pharming's (PHAR) quarterly Profit After Tax came in at $28.0 million in Q2 2026, up 397.58% YoY from $5.6 million in Q2 2025, and up 296.42% on a QoQ basis from -$14.3 million in Q1 2026.
Pharming (PHAR) Profit After Tax (2020 - 2026) Analysis & Trends
Pharming (PHAR) has 7 years of Profit After Tax data on file, last reported at $28.0 million in Q2 2026.
- Quarterly Profit After Tax rose 397.58% year-over-year to $28.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $28.0 million (up 353.83% YoY) and the FY2025 annual result came in at $2.5 million, up 121.43% from the prior year.
- Profit After Tax grew to $28.0 million in Q2 2026, from -$14.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $28.0 million in Q2 2026 to a low of -$20.5 million in Q1 2024.
- A 5-year average of -$1.5 million and a median of -$4.1 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax plunged 5877.78% — and 2025, when it jumped 1623.38%.
- Tracing PHAR's Profit After Tax over 5 years: stood at $13.6 million in 2022, then plunged by 188.03% to -$12.0 million in 2023, then soared by 57.18% to -$5.1 million in 2024, then slumped by 130.24% to -$11.8 million in 2025, then jumped by 336.54% to $28.0 million in 2026.
- The last three Profit After Tax figures came in at $28.0 million (Q2 2026), -$14.3 million (Q1 2026), and -$11.8 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | 28.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.01 Mn |
| Mar 31, 2026 | -14.26 Mn |
| Dec 31, 2025 | -11.84 Mn |
| Sep 30, 2025 | 26.09 Mn |
| Jun 30, 2025 | 5.63 Mn |
| Mar 31, 2025 | -13.03 Mn |
| Dec 31, 2024 | -5.14 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Mar 31, 2024 | -20.49 Mn |
| Dec 31, 2023 | -12.01 Mn |
| Sep 30, 2023 | 3.15 Mn |
| Jun 30, 2023 | -13.29 Mn |
| Mar 31, 2023 | -18.13 Mn |
| Dec 31, 2022 | 13.65 Mn |
| Sep 30, 2022 | -19.17 Mn |
| Jun 30, 2022 | 21.59 Mn |
| Mar 31, 2022 | 3.60 Mn |
| Dec 31, 2021 | 14.40 Mn |
| Sep 30, 2021 | -320,766.15 |